{"id":57552,"date":"2023-06-08T22:03:46","date_gmt":"2023-06-08T20:03:46","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/veradigm-payerpath-rated-1-end-to-end-revenue-cycle-management-rcm-software\/"},"modified":"2023-06-08T22:03:46","modified_gmt":"2023-06-08T20:03:46","slug":"veradigm-payerpath-rated-1-end-to-end-revenue-cycle-management-rcm-software","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/veradigm-payerpath-rated-1-end-to-end-revenue-cycle-management-rcm-software\/","title":{"rendered":"Veradigm Payerpath\u2122 Rated #1 End-to-End Revenue Cycle Management (RCM) Software"},"content":{"rendered":"
\n

\nAnnual survey results reveal company receives top ranking in RCM setting for the second consecutive year<\/i><\/p>\n

CHICAGO–(BUSINESS WIRE)–#healthIT<\/a>–Veradigm\u00ae <\/sup>(NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, announced that Black Book<\/a>, a healthcare-centric market research and public opinion research and consulting company, has honored Veradigm Payerpath with the highest ranking in its End-to-End RCM Software Technology, Physician Practices & Ambulatory Facilities\/Groups<\/a> category for 2023.<\/p>\n

\nBlack Book conducted polls and surveys with healthcare executives and front-line users about their current technology and services partners and awarded top-performing vendors based on 18 key performance indicators of client experience, loyalty, and customer satisfaction.<\/p>\n

\nVeradigm Payerpath is an end-to-end revenue cycle management suite of solutions built to assist organizations improve revenue, streamline communications with payers and patients, and boost practice profitability for practices of all sizes and specialties.<\/p>\n

\n\u201cVeradigm Payerpath seamlessly connects patients, providers, and payers via the Veradigm Network,\u201d said Tom Langan, President and Chief Commercial Officer of Veradigm. \u201cVeradigm is dedicated to helping streamline patient interactions and support providers as they take control of their revenue cycle. We are proud that Black Book and its survey participants have recognized the value Payerpath brings to the ambulatory market.\u201d<\/p>\n

\nAbout Veradigm\u00ae<\/b><\/p>\n

\nVeradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions, all working together to transform healthcare insightfully. For more information on Veradigm, visit http:\/\/www.veradigm.com<\/a>, or find Veradigm on LinkedIn<\/a>, Facebook<\/a>, Twitter<\/a>, and YouTube<\/a><\/p>\n

\n\u00a9 2023 Veradigm LLC and\/or its affiliates. All rights reserved. Cited marks are the property of Veradigm LLC and\/or its affiliates. All other product or company names are the property of their respective holders, all rights reserved.<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestors:<\/span>
Jenny Gelinas
\n
312-506-1237
\n
Jenny.Gelinas@veradigm.com<\/a><\/p>\n

\nMedia:<\/span>
Concetta Rasiarmos
\n
312-447-2466
\n
concetta.rasiarmos@veradigm.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Annual survey results reveal company receives top ranking in RCM setting for the second consecutive year CHICAGO–(BUSINESS WIRE)–#healthIT–Veradigm\u00ae (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, announced that Black Book, a healthcare-centric market research and public opinion research and consulting company, has honored Veradigm Payerpath with the highest ranking in its End-to-End … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-57552","6":"format-standard","7":"category-industry"},"yoast_head":"\nVeradigm Payerpath\u2122 Rated #1 End-to-End Revenue Cycle Management (RCM) Software - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/veradigm-payerpath-rated-1-end-to-end-revenue-cycle-management-rcm-software\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Veradigm Payerpath\u2122 Rated #1 End-to-End Revenue Cycle Management (RCM) Software - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Annual survey results reveal company receives top ranking in RCM setting for the second consecutive year CHICAGO–(BUSINESS WIRE)–#healthIT–Veradigm\u00ae (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, announced that Black Book, a healthcare-centric market research and public opinion research and consulting company, has honored Veradigm Payerpath with the highest ranking in its End-to-End ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/veradigm-payerpath-rated-1-end-to-end-revenue-cycle-management-rcm-software\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-08T20:03:46+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/veradigm-payerpath-rated-1-end-to-end-revenue-cycle-management-rcm-software\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/veradigm-payerpath-rated-1-end-to-end-revenue-cycle-management-rcm-software\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Veradigm Payerpath\u2122 Rated #1 End-to-End Revenue Cycle Management (RCM) Software\",\"datePublished\":\"2023-06-08T20:03:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/veradigm-payerpath-rated-1-end-to-end-revenue-cycle-management-rcm-software\\\/\"},\"wordCount\":330,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/veradigm-payerpath-rated-1-end-to-end-revenue-cycle-management-rcm-software\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/veradigm-payerpath-rated-1-end-to-end-revenue-cycle-management-rcm-software\\\/\",\"name\":\"Veradigm Payerpath\u2122 Rated #1 End-to-End Revenue Cycle Management (RCM) Software - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2023-06-08T20:03:46+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/veradigm-payerpath-rated-1-end-to-end-revenue-cycle-management-rcm-software\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/veradigm-payerpath-rated-1-end-to-end-revenue-cycle-management-rcm-software\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/veradigm-payerpath-rated-1-end-to-end-revenue-cycle-management-rcm-software\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Veradigm Payerpath\u2122 Rated #1 End-to-End Revenue Cycle Management (RCM) Software\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Veradigm Payerpath\u2122 Rated #1 End-to-End Revenue Cycle Management (RCM) Software - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/veradigm-payerpath-rated-1-end-to-end-revenue-cycle-management-rcm-software\/","og_locale":"en_US","og_type":"article","og_title":"Veradigm Payerpath\u2122 Rated #1 End-to-End Revenue Cycle Management (RCM) Software - Pharma Trend","og_description":"Annual survey results reveal company receives top ranking in RCM setting for the second consecutive year CHICAGO–(BUSINESS WIRE)–#healthIT–Veradigm\u00ae (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, announced that Black Book, a healthcare-centric market research and public opinion research and consulting company, has honored Veradigm Payerpath with the highest ranking in its End-to-End ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/veradigm-payerpath-rated-1-end-to-end-revenue-cycle-management-rcm-software\/","og_site_name":"Pharma Trend","article_published_time":"2023-06-08T20:03:46+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/veradigm-payerpath-rated-1-end-to-end-revenue-cycle-management-rcm-software\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/veradigm-payerpath-rated-1-end-to-end-revenue-cycle-management-rcm-software\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Veradigm Payerpath\u2122 Rated #1 End-to-End Revenue Cycle Management (RCM) Software","datePublished":"2023-06-08T20:03:46+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/veradigm-payerpath-rated-1-end-to-end-revenue-cycle-management-rcm-software\/"},"wordCount":330,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/veradigm-payerpath-rated-1-end-to-end-revenue-cycle-management-rcm-software\/","url":"https:\/\/pharma-trend.com\/en\/veradigm-payerpath-rated-1-end-to-end-revenue-cycle-management-rcm-software\/","name":"Veradigm Payerpath\u2122 Rated #1 End-to-End Revenue Cycle Management (RCM) Software - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2023-06-08T20:03:46+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/veradigm-payerpath-rated-1-end-to-end-revenue-cycle-management-rcm-software\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/veradigm-payerpath-rated-1-end-to-end-revenue-cycle-management-rcm-software\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/veradigm-payerpath-rated-1-end-to-end-revenue-cycle-management-rcm-software\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Veradigm Payerpath\u2122 Rated #1 End-to-End Revenue Cycle Management (RCM) Software"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/57552","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=57552"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/57552\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=57552"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=57552"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=57552"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}